Skip to main content
UHSUniversal Health Services, Inc.Sell5.5·$196.46
SellModerate Confidence
Investment thesis

Universal Health Services trades at a forward P/E of just 5.8x with a reward-to-risk ratio of 7.89 and 33% analyst upside, offering deep value relative to healthcare facility peers, though confirmed downtrend momentum and an elevated put/call ratio of 2.17 create near-term headwinds.

Thesis pillars

  • Deep Value Forward Pe At 5x↓Deteriorating
  • Strong Earnings Beat With Analyst Upside↓Deteriorating
  • Confirmed Downtrend Death Cross Block↑Improving
  • +1 more pillar — see the Why tab for full reasoning

Pillars as of Jul 3, 2026, based on the 10-K filed Feb 25, 2026· older than 90 days

Full reasoning →

Open full analysis

Universal Health Services, Inc. (UHS) Stock Analysis

Breakout setup

SellValueQualityModerate Confidence

Healthcare · Medical Care Facilities

Sell if holding. Analyst target reached at $196.46 — A.R:R is negative (-0.8) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: V7 low-quality RISK_OFF penalty: -0.5 (Q=5.3).

Universal Health Services owns and operates acute care hospitals, behavioral health facilities, and outpatient centers across 40 states, Washington D.C., the United Kingdom, and Puerto Rico, with 375 inpatient and 168 outpatient facilities as of February 2026. Revenue comes from... Read more

$196.46-11.9% A.UpsideScore 5.5/10#23 of 35 Medical Care Facilities
QualityF-score7 / 9FCF yield6.43%
IncomeYield0.41%(5y avg 0.49%)Payout3.26%sustainable
Stop $182.71Analyst target $173.17(reached)A.R:R -0.8:1
Analyst consensus$192.41-2.1%17 analysts with price targets
$196.46price
$192.41mean
$156
$250

Sell if holding. Analyst target reached at $196.46 — A.R:R is negative (-0.8) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: V7 low-quality RISK_OFF penalty: -0.5 (Q=5.3). Chart setup: Golden cross, above all MAs, RSI 57, MACD bullish. Score 5.5/10, moderate confidence.

Passes 6/8 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 111d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated Nov 4, 2026

Recent Developments — Universal Health Services, Inc.

Latest item Nov 4, 2026 · Generated 2026-11-05T11:49:11Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Feb 24, 2027111d to earnings· next earnings call

Thesis

Rewards
Sector modifier (Healthcare): +0.5
Attractive valuation
Positive momentum
Risks
Analyst target reached - limited upside remaining
V7 low-quality RISK_OFF penalty: -0.5 (Q=5.3)
Consecutive earnings misses (2)

Key Metrics

P/E (TTM)8.2
P/E (Fwd)8.5
Mkt Cap$11.6B
EV/EBITDA6.7
Profit Mgn8.0%
ROE19.7%
Rev Growth5.3%
Beta1.11
Dividend0.41%
Analysts with ratings25

Quality Signals

Piotroski F7/9MoatNarrow

Options Flow

P/C8.00bearish
IV47%normal
Max Pain$120-38.9% vs spot

Concentration Risks(10-K Item 1A)

  • LOWGeographicNevada17%
    10-K Item 1A: 'Nevada: We own 10 inpatient acute care hospitals ... these facilities contributed 17% of our consolidated net revenues during each of 2025 and 2024'
  • LOWGeographicTexas16%
    10-K Item 1A: 'Texas: We own 7 inpatient acute care hospitals ... these facilities contributed 16% of our consolidated net revenues during each of 2025 and 2024'
  • LOWGeographicCalifornia11%
    10-K Item 1A: 'California: We own 5 inpatient acute care hospitals ... these facilities contributed 11% of our consolidated net revenues during each of 2025 and 2024'

Material Events(8-K, last 90d)

  • 2026-05-21Item 5.02MEDIUM
    Matthew J. Peterson, EVP and President, Behavioral Health, resigned effective June 19, 2026, to pursue an external career opportunity. CEO Marc D. Miller assumes interim responsibilities for the Behavioral Health Care Division; search for permanent replacement underway. No disagreement cited.
    SEC filing →
  • 2026-03-30Item 5.02LOW
    Compensation Committee approved 2026 annual incentive bonus formulae for executive officers and a $1.07 million discretionary cash bonus for Executive Chairman Alan B. Miller for 2025. Routine compensatory arrangement; no departure or appointment.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers·1 ceiling hit

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Earnings Growth
0.0
Revenue Growth
3.8

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
0.0
Support Resistance
0.4
Gap
3.0
52w Position
6.0
Extreme gap up (5.0%) - may pull back
GatesA.R:R -0.8=NEGATIVEExecutive change: officer departure/appointmentMomentum 8.8>=5.5Insider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 111d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARBreakoutSuitability: Moderate
RSI
57 · Neutral
↑ 20D MA↑ 50D MA↑ 200D MAGOLDEN CROSSSupport $169.12Resistance $197.62

Price Targets

A.Upside-11.9%
A.R:R-0.8:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeRisk-Off

Risk Alerts

! Target reached (-11.9% upside)
! Negative risk/reward — downside exceeds upside

Earnings

B
B
M
M
2/4 beats
Next Earnings2027-02-24 (111d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is UHS stock a buy right now?

Sell if holding. Analyst target reached at $196.46 — A.R:R is negative (-0.8) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: V7 low-quality RISK_OFF penalty: -0.5 (Q=5.3). Chart setup: Golden cross, above all MAs, RSI 57, MACD bullish. Prior stop was $182.71. Score 5.5/10, moderate confidence.

What is the UHS stock price target?

Analyst target $173.17 reached (−11.9% from $196.46); no take-profit level is published. Prior stop was $182.71. Stop-loss: $182.71.

What are the risks of investing in UHS?

Analyst target reached - limited upside remaining; V7 low-quality RISK_OFF penalty: -0.5 (Q=5.3); Consecutive earnings misses (2).

Is UHS overvalued or undervalued?

Universal Health Services, Inc. trades at a P/E of 8.2 (forward 8.5). TrendMatrix value score: 7.2/10. Verdict: Sell.

What do analysts say about UHS?

25 analysts rate UHS, with a consensus score of 3.4/5. 17 analysts publish price targets averaging $192.

What does Universal Health Services, Inc. do?Universal Health Services owns and operates acute care hospitals, behavioral health facilities, and outpatient centers...

Universal Health Services owns and operates acute care hospitals, behavioral health facilities, and outpatient centers across 40 states, Washington D.C., the United Kingdom, and Puerto Rico, with 375 inpatient and 168 outpatient facilities as of February 2026. Revenue comes from Medicare, Medicaid, and private insurers, with acute care generating approximately 57% of consolidated net revenues and behavioral health approximately 43%; U.K. operations contributed approximately $1.0 billion in 2025.

Related stocks: ASTH (Astrana Health Inc.) · AVAH (Aveanna Healthcare Holdings Inc) · THC (Tenet Healthcare Corporation) · ADUS (Addus HomeCare Corporation) · GRDN (Guardian Pharmacy Services, Inc)
Home › Stocks › UHS

Latest news

Latest News

Yahoo Finance106d agoEarnings
GuruFocus106d ago
Yahoo Finance197d ago
Yahoo Finance197d agoEarnings
TradingKey141d ago
AD HOC NEWS141d agoAnalyst
Sahm148d ago
Kalkine Media9d ago
Yahoo Finance9d ago
Www.marketscreener.com9d agoEarnings
StockStory9d agoEarnings
TIKR.com9d ago
Marketscreener.com107d ago
TipRanks107d ago
The Globe and Mail198d agoEarnings
TradingView198d agoEarnings
Seeking Alpha16d ago
Yahoo Finance16d agoEarnings
AD HOC NEWS142d agoEarnings
AD HOC NEWS142d ago
Loading more...